Search details
1.
HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.
Br J Cancer
; 118(3): 378-387, 2018 02 06.
Article
in English
| MEDLINE | ID: mdl-29169184
2.
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
Proc Natl Acad Sci U S A
; 109(22): 8699-704, 2012 May 29.
Article
in English
| MEDLINE | ID: mdl-22589302
3.
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
Mod Pathol
; 26(3): 428-34, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23080032
4.
Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer.
Am J Pathol
; 178(2): 861-71, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21281818
5.
Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation.
BMC Cancer
; 12: 21, 2012 Jan 17.
Article
in English
| MEDLINE | ID: mdl-22251838
6.
Lipocalin 2 expression is associated with aggressive features of endometrial cancer.
BMC Cancer
; 12: 169, 2012 May 06.
Article
in English
| MEDLINE | ID: mdl-22559235
7.
Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.
Eur J Haematol
; 84(3): 239-51, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-19922462
8.
Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators.
Br J Haematol
; 144(1): 53-68, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-19016730
9.
Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain.
Pharmacol Res Perspect
; 6(6): e00437, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30410767
10.
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.
PLoS One
; 13(11): e0206665, 2018.
Article
in English
| MEDLINE | ID: mdl-30383835
11.
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.
Sci Rep
; 7(1): 10240, 2017 08 31.
Article
in English
| MEDLINE | ID: mdl-28860563
12.
Androgen receptor as potential therapeutic target in metastatic endometrial cancer.
Oncotarget
; 7(31): 49289-49298, 2016 Aug 02.
Article
in English
| MEDLINE | ID: mdl-27384477
13.
Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300.
J Mol Biol
; 337(4): 773-88, 2004 Apr 02.
Article
in English
| MEDLINE | ID: mdl-15033350
14.
Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer.
Histopathology
; 57(4): 641-6, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20955391
15.
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses.
Oncotarget
; 6(37): 39676-91, 2015 Nov 24.
Article
in English
| MEDLINE | ID: mdl-26485755
16.
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.
Oncotarget
; 6(12): 10634-45, 2015 Apr 30.
Article
in English
| MEDLINE | ID: mdl-25860936
17.
ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.
Oncotarget
; 6(29): 28440-52, 2015 Sep 29.
Article
in English
| MEDLINE | ID: mdl-26308378
18.
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
Oncotarget
; 6(2): 1327-39, 2015 Jan 20.
Article
in English
| MEDLINE | ID: mdl-25415225
19.
Switch in FOXA1 status associates with endometrial cancer progression.
PLoS One
; 9(5): e98069, 2014.
Article
in English
| MEDLINE | ID: mdl-24849812
20.
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Oncotarget
; 5(4): 1052-61, 2014 Feb 28.
Article
in English
| MEDLINE | ID: mdl-24658009